|1.||Setnikar, Ivo: 1 article (05/2002)|
|2.||Ringe, Johann Diederich: 1 article (05/2002)|
05/01/2002 - "The results were compared with those of a previous study conducted in the same center with a similar protocol with a calcium supplement on patients suffering from postmenopausal established osteoporosis and treated with MFP/Ca but without HRT. "
05/01/2002 - "A 3-year, open-label, monocenter study was performed on 60 patients with postmenopausal established osteoporosis treated with monofluorophosphate and calcium supplement (MFP/Ca) combined with hormone replacement therapy (HRT). "
|2.||Asthma (Bronchial Asthma)
01/01/1996 - "Patients (n = 35), who had been treated for 1 year or more with prednisone-equivalent doses > or = 7 mg/day for asthma or other respiratory diseases, were randomly assigned to receive twice a day, for 2 years, either one MFP-Ca tablet [100 mg sodium monofluorophosphate (13.2 mg F-) + 500.5 mg Ca2+] or one Ca tablet (500.5 mg Ca2+). "
|1.||fluorophosphate (sodium monofluorophosphate)
|1.||Hormone Replacement Therapy (Therapy, Hormone Replacement)